The Scharioth implant is an intraocular sulcus lens with a bifocal design. A 1.5mm diameter zone in the centre of the lens has a power of +10 dioptres to give high magnification of reading tasks. The periphery of the implant is neutral in order to maintain good distance vision. The implant is only required to be placed in one eye and this is predominantly the eye with the better quality of vision. Cataract surgery will be performed prior to implantation of this lens if required. The lens implanted from cataract surgery and the Macula Scharioth lens can comfortably co-exist to maximise the vision in an eye with dry AMD.

In the weeks following treatment, patients are encouraged to practise near vision tasks without the assistance of their low vision aids. Optimal lighting and high contrast reading material should be used where feasible. Individuals will need to hold their reading material at 15-18 centimetres in order to get it into focus. In total, 2-5 weeks of adaptation may be required to fully adjust to the Scharioth macula implant.

The Scharioth macula implant does not treat age-related macular degeneration but does help to maximise the remaining vision. It is therefore possible for wet macular degeneration to develop following implantation of the lens. Reassuringly, anti-VEGF injections can still be used following implantation of the lens.